speb/financial-data huggingface dataset:
EXPLEOSOL.NS cash_flow (annual, 2026-03-31) — Interest Received Cfi: 105820000.00
EXPLEOSOL.NS balance_sheet (annual, 2026-03-31) — Invested Capital: 7763120000.00
EXPLEOSOL.NS balance_sheet (quarterly, 2026-03-31) — Invested Capital: 7763120000.00
EXPLEOSOL.NS cash_flow (annual, 2026-03-31) — Investing Cash Flow: 318670000.00
EXPLEOSOL.NS balance_sheet (annual, 2026-03-31) — Investmentin Financial Assets: 42000000.00
EXPLEOSOL.NS balance_sheet (quarterly, 2026-03-31) — Investmentin Financial Assets: 42000000.00
EXPLEOSOL.NS balance_sheet (annual, 2026-03-31) — Long Term Capital Lease Obligation: 50580000.00
EXPLEOSOL.NS balance_sheet (quarterly, 2026-03-31) — Long Term Capital Lease Obligation: 50580000.00
EXPLEOSOL.NS balance_sheet (annual, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 50580000.00
EXPLEOSOL.NS balance_sheet (quarterly, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 50580000.00
EXPLEOSOL.NS balance_sheet (annual, 2026-03-31) — Long Term Provisions: 193740000.00
EXPLEOSOL.NS balance_sheet (quarterly, 2026-03-31) — Long Term Provisions: 193740000.00
EXPLEOSOL.NS income_statement (annual, 2026-03-31) — Minority Interests: 0.00
EXPLEOSOL.NS income_statement (quarterly, 2026-03-31) — Minority Interests: 0.00
EXPLEOSOL.NS cash_flow (annual, 2026-03-31) — Net Foreign Currency Exchange Gain Loss: -18110000.00
EXPLEOSOL.NS income_statement (annual, 2026-03-31) — Net Income: 1239820000.00
EXPLEOSOL.NS income_statement (quarterly, 2026-03-31) — Net Income: 416700000.00
EXPLEOSOL.NS income_statement (annual, 2026-03-31) — Net Income Common Stockholders: 1239820000.00
EXPLEOSOL.NS income_statement (quarterly, 2026-03-31) — Net Income Common Stockholders: 416700000.00
EXPLEOSOL.NS income_statement (annual, 2026-03-31) — Net Income Continuous Operations: 1239820000.00
EXPLEOSOL.NS income_statement (quarterly, 2026-03-31) — Net Income Continuous Operations: 416700000.00
EXPLEOSOL.NS income_statement (annual, 2026-03-31) — Net Income From Continuing And Discontinued Operation: 1239820000.00
EXPLEOSOL.NS income_statement (quarterly, 2026-03-31) — Net Income From Continuing And Discontinued Operation: 416700000.00
EXPLEOSOL.NS income_statement (annual, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: 1239820000.00
EXPLEOSOL.NS income_statement (quarterly, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: 416700000.00
EXPLEOSOL.NS cash_flow (annual, 2026-03-31) — Net Income From Continuing Operations: 1625650000.00
EXPLEOSOL.NS income_statement (annual, 2026-03-31) — Net Income Including Noncontrolling Interests: 1239820000.00
EXPLEOSOL.NS income_statement (quarterly, 2026-03-31) — Net Income Including Noncontrolling Interests: 416700000.00
EXPLEOSOL.NS income_statement (annual, 2026-03-31) — Net Interest Income: -22350000.00
EXPLEOSOL.NS income_statement (quarterly, 2026-03-31) — Net Interest Income: -5730000.00
EXPLEOSOL.NS cash_flow (annual, 2026-03-31) — Net Investment Purchase And Sale: -59110000.00
EXPLEOSOL.NS income_statement (annual, 2026-03-31) — Net Non Operating Interest Income Expense: -22350000.00
EXPLEOSOL.NS income_statement (quarterly, 2026-03-31) — Net Non Operating Interest Income Expense: -5730000.00
EXPLEOSOL.NS balance_sheet (annual, 2026-03-31) — Net PPE: 721800000.00
EXPLEOSOL.NS balance_sheet (quarterly, 2026-03-31) — Net PPE: 721800000.00
EXPLEOSOL.NS cash_flow (annual, 2026-03-31) — Net PPE Purchase And Sale: -29520000.00
EXPLEOSOL.NS balance_sheet (annual, 2026-03-31) — Net Tangible Assets: 7758200000.00
EXPLEOSOL.NS balance_sheet (quarterly, 2026-03-31) — Net Tangible Assets: 7758200000.00
EXPLEOSOL.NS balance_sheet (annual, 2026-03-31) — Non Current Deferred Taxes Assets: 83020000.00
EXPLEOSOL.NS balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Taxes Assets: 83020000.00
EXPLEOSOL.NS balance_sheet (annual, 2026-03-31) — Non Current Prepaid Assets: 236180000.00
EXPLEOSOL.NS balance_sheet (quarterly, 2026-03-31) — Non Current Prepaid Assets: 236180000.00
EXPLEOSOL.NS income_statement (annual, 2026-03-31) — Normalized EBITDA: 2078540000.00
EXPLEOSOL.NS income_statement (quarterly, 2026-03-31) — Normalized EBITDA: 553130000.00
EXPLEOSOL.NS income_statement (annual, 2026-03-31) — Normalized Income: 1352144725.25
EXPLEOSOL.NS income_statement (quarterly, 2026-03-31) — Normalized Income: 399829886.21
EXPLEOSOL.NS cash_flow (annual, 2026-03-31) — Operating Cash Flow: 1194660000.00
EXPLEOSOL.NS income_statement (annual, 2026-03-31) — Operating Income: 1416400000.00
EXPLEOSOL.NS income_statement (quarterly, 2026-03-31) — Operating Income: 368180000.00
EXPLEOSOL.NS income_statement (annual, 2026-03-31) — Operating Revenue: 11079630000.00
EXPLEOSOL.NS income_statement (quarterly, 2026-03-31) — Operating Revenue: 2862750000.00
EXPLEOSOL.NS balance_sheet (annual, 2026-03-31) — Ordinary Shares Number: 15519739.00
EXPLEOSOL.NS balance_sheet (quarterly, 2026-03-31) — Ordinary Shares Number: 15519739.00
EXPLEOSOL.NS balance_sheet (annual, 2026-03-31) — Other Current Assets: 306930000.00
EXPLEOSOL.NS balance_sheet (quarterly, 2026-03-31) — Other Current Assets: 306930000.00
EXPLEOSOL.NS balance_sheet (annual, 2026-03-31) — Other Current Liabilities: 228870000.00
EXPLEOSOL.NS balance_sheet (quarterly, 2026-03-31) — Other Current Liabilities: 228870000.00
EXPLEOSOL.NS balance_sheet (annual, 2026-03-31) — Other Equity Interest: 7607920000.00
EXPLEOSOL.NS balance_sheet (quarterly, 2026-03-31) — Other Equity Interest: 7607920000.00
EXPLEOSOL.NS balance_sheet (annual, 2026-03-31) — Other Intangible Assets: 4920000.00
EXPLEOSOL.NS balance_sheet (quarterly, 2026-03-31) — Other Intangible Assets: 4920000.00
EXPLEOSOL.NS cash_flow (annual, 2026-03-31) — Other Non Cash Items: 3700000.00
EXPLEOSOL.NS balance_sheet (annual, 2026-03-31) — Other Non Current Assets: 113910000.00
EXPLEOSOL.NS balance_sheet (quarterly, 2026-03-31) — Other Non Current Assets: 113910000.00
EXPLEOSOL.NS income_statement (annual, 2026-03-31) — Other Non Operating Income Expenses: 378800000.00
EXPLEOSOL.NS income_statement (quarterly, 2026-03-31) — Other Non Operating Income Expenses: 125780000.00
EXPLEOSOL.NS income_statement (annual, 2026-03-31) — Other Operating Expenses: 2333590000.00
EXPLEOSOL.NS income_statement (quarterly, 2026-03-31) — Other Operating Expenses: 555240000.00
EXPLEOSOL.NS balance_sheet (annual, 2026-03-31) — Other Properties: 721800000.00
EXPLEOSOL.NS balance_sheet (quarterly, 2026-03-31) — Other Properties: 721800000.00
EXPLEOSOL.NS balance_sheet (annual, 2026-03-31) — Other Short Term Investments: 966770000.00
EXPLEOSOL.NS balance_sheet (quarterly, 2026-03-31) — Other Short Term Investments: 966770000.00
EXPLEOSOL.NS income_statement (annual, 2026-03-31) — Other Special Charges: 147280000.00
EXPLEOSOL.NS income_statement (quarterly, 2026-03-31) — Other Special Charges: -20600000.00
EXPLEOSOL.NS income_statement (annual, 2026-03-31) — Otherunder Preferred Stock Dividend: 0.00
EXPLEOSOL.NS income_statement (quarterly, 2026-03-31) — Otherunder Preferred Stock Dividend: 0.00
EXPLEOSOL.NS balance_sheet (annual, 2026-03-31) — Payables: 667100000.00
EXPLEOSOL.NS balance_sheet (quarterly, 2026-03-31) — Payables: 667100000.00
EXPLEOSOL.NS income_statement (annual, 2026-03-31) — Pretax Income: 1625650000.00
EXPLEOSOL.NS income_statement (quarterly, 2026-03-31) — Pretax Income: 508830000.00
EXPLEOSOL.NS cash_flow (annual, 2026-03-31) — Provisionand Write Offof Assets: -11260000.00
EXPLEOSOL.NS cash_flow (annual, 2026-03-31) — Purchase Of Investment: -7732720000.00
EXPLEOSOL.NS cash_flow (annual, 2026-03-31) — Purchase Of PPE: -29640000.00
EXPLEOSOL.NS income_statement (annual, 2026-03-31) — Reconciled Cost Of Revenue: 7046380000.00
EXPLEOSOL.NS income_statement (quarterly, 2026-03-31) — Reconciled Cost Of Revenue: 1880160000.00
EXPLEOSOL.NS income_statement (annual, 2026-03-31) — Reconciled Depreciation: 283260000.00
EXPLEOSOL.NS income_statement (quarterly, 2026-03-31) — Reconciled Depreciation: 59170000.00
EXPLEOSOL.NS cash_flow (annual, 2026-03-31) — Sale Of Investment: 7673610000.00
EXPLEOSOL.NS cash_flow (annual, 2026-03-31) — Sale Of PPE: 120000.00
EXPLEOSOL.NS balance_sheet (annual, 2026-03-31) — Share Issued: 15519739.00
EXPLEOSOL.NS balance_sheet (quarterly, 2026-03-31) — Share Issued: 15519739.00
EXPLEOSOL.NS income_statement (annual, 2026-03-31) — Special Income Charges: -147280000.00
EXPLEOSOL.NS income_statement (quarterly, 2026-03-31) — Special Income Charges: 20600000.00
EXPLEOSOL.NS balance_sheet (annual, 2026-03-31) — Stockholders Equity: 7763120000.00
EXPLEOSOL.NS balance_sheet (quarterly, 2026-03-31) — Stockholders Equity: 7763120000.00
EXPLEOSOL.NS balance_sheet (annual, 2026-03-31) — Tangible Book Value: 7758200000.00
EXPLEOSOL.NS balance_sheet (quarterly, 2026-03-31) — Tangible Book Value: 7758200000.00
EXPLEOSOL.NS income_statement (annual, 2026-03-31) — Tax Effect Of Unusual Items: -34955274.75
EXPLEOSOL.NS income_statement (quarterly, 2026-03-31) — Tax Effect Of Unusual Items: 3729886.21
EXPLEOSOL.NS income_statement (annual, 2026-03-31) — Tax Provision: 385830000.00
EXPLEOSOL.NS income_statement (quarterly, 2026-03-31) — Tax Provision: 92130000.00
EXPLEOSOL.NS income_statement (annual, 2026-03-31) — Tax Rate For Calcs: 0.24
EXPLEOSOL.NS income_statement (quarterly, 2026-03-31) — Tax Rate For Calcs: 0.18
EXPLEOSOL.NS cash_flow (annual, 2026-03-31) — Taxes Refund Paid: -415930000.00
EXPLEOSOL.NS balance_sheet (annual, 2026-03-31) — Total Assets: 9288270000.00
EXPLEOSOL.NS balance_sheet (quarterly, 2026-03-31) — Total Assets: 9288270000.00
EXPLEOSOL.NS balance_sheet (annual, 2026-03-31) — Total Capitalization: 7763120000.00
EXPLEOSOL.NS balance_sheet (quarterly, 2026-03-31) — Total Capitalization: 7763120000.00
EXPLEOSOL.NS balance_sheet (annual, 2026-03-31) — Total Debt: 78520000.00
EXPLEOSOL.NS balance_sheet (quarterly, 2026-03-31) — Total Debt: 78520000.00
EXPLEOSOL.NS balance_sheet (annual, 2026-03-31) — Total Equity Gross Minority Interest: 7763120000.00
EXPLEOSOL.NS balance_sheet (quarterly, 2026-03-31) — Total Equity Gross Minority Interest: 7763120000.00
EXPLEOSOL.NS income_statement (annual, 2026-03-31) — Total Expenses: 9663230000.00
EXPLEOSOL.NS income_statement (quarterly, 2026-03-31) — Total Expenses: 2494570000.00
EXPLEOSOL.NS balance_sheet (annual, 2026-03-31) — Total Liabilities Net Minority Interest: 1525150000.00
EXPLEOSOL.NS balance_sheet (quarterly, 2026-03-31) — Total Liabilities Net Minority Interest: 1525150000.00
EXPLEOSOL.NS balance_sheet (annual, 2026-03-31) — Total Non Current Assets: 2176460000.00
EXPLEOSOL.NS balance_sheet (quarterly, 2026-03-31) — Total Non Current Assets: 2176460000.00
EXPLEOSOL.NS balance_sheet (annual, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 244320000.00
EXPLEOSOL.NS balance_sheet (quarterly, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 244320000.00
EXPLEOSOL.NS balance_sheet (annual, 2026-03-31) — Total Tax Payable: 95690000.00
EXPLEOSOL.NS balance_sheet (quarterly, 2026-03-31) — Total Tax Payable: 95690000.00
EXPLEOSOL.NS income_statement (annual, 2026-03-31) — Total Unusual Items: -147280000.00
EXPLEOSOL.NS income_statement (quarterly, 2026-03-31) — Total Unusual Items: 20600000.00
EXPLEOSOL.NS income_statement (annual, 2026-03-31) — Total Unusual Items Excluding Goodwill: -147280000.00
EXPLEOSOL.NS income_statement (quarterly, 2026-03-31) — Total Unusual Items Excluding Goodwill: 20600000.00
EXPLEOSOL.NS balance_sheet (annual, 2026-03-31) — Working Capital: 5830980000.00
EXPLEOSOL.NS balance_sheet (quarterly, 2026-03-31) — Working Capital: 5830980000.00
EXPN.L income_statement (annual, 2022-03-31) — +Operating Expense: 1606000000.00
EXPN.L income_statement (annual, 2022-03-31) — +Total Revenue: 6288000000.00
EXPN.L balance_sheet (annual, 2022-03-31) — Accounts Payable: 1744000000.00
EXPN.L balance_sheet (annual, 2022-03-31) — Accounts Receivable: 1409000000.00
EXPN.L balance_sheet (annual, 2022-03-31) — Accumulated Depreciation: -740000000.00
EXPN.L balance_sheet (annual, 2022-03-31) — Additional Paid In Capital: 1780000000.00
EXPN.L income_statement (annual, 2022-03-31) — Amortization: 174000000.00
EXPN.L balance_sheet (annual, 2022-03-31) — Assets Held For Sale Current: 41000000.00
EXPN.L balance_sheet (annual, 2022-03-31) — Available For Sale Securities: 456000000.00
EXPN.L income_statement (annual, 2022-03-31) — Basic Average Shares: 914000000.00
EXPN.L income_statement (annual, 2022-03-31) — Basic EPS: 1.28
EXPN.L cash_flow (annual, 2022-03-31) — Beginning Cash Position: 170000000.00
EXPN.L balance_sheet (annual, 2022-03-31) — Buildings And Improvements: 361000000.00
EXPN.L cash_flow (annual, 2022-03-31) — Capital Expenditure: -508000000.00
EXPN.L balance_sheet (annual, 2022-03-31) — Capital Lease Obligations: 179000000.00
EXPN.L balance_sheet (annual, 2022-03-31) — Capital Stock: 96000000.00
EXPN.L balance_sheet (annual, 2022-03-31) — Cash And Cash Equivalents: 179000000.00
EXPN.L balance_sheet (annual, 2022-03-31) — Cash Cash Equivalents And Short Term Investments: 186000000.00
EXPN.L cash_flow (annual, 2022-03-31) — Cash Dividends Paid: -446000000.00
EXPN.L balance_sheet (annual, 2022-03-31) — Cash Equivalents: 75000000.00
EXPN.L balance_sheet (annual, 2022-03-31) — Cash Financial: 104000000.00
EXPN.L cash_flow (annual, 2022-03-31) — Change In Payable: 201000000.00
EXPN.L cash_flow (annual, 2022-03-31) — Change In Receivables: -143000000.00
EXPN.L cash_flow (annual, 2022-03-31) — Change In Working Capital: 58000000.00
EXPN.L cash_flow (annual, 2022-03-31) — Changes In Cash: -8000000.00
EXPN.L balance_sheet (annual, 2022-03-31) — Common Stock: 96000000.00
EXPN.L cash_flow (annual, 2022-03-31) — Common Stock Dividend Paid: -446000000.00
EXPN.L balance_sheet (annual, 2022-03-31) — Common Stock Equity: 3969000000.00
EXPN.L cash_flow (annual, 2022-03-31) — Common Stock Issuance: 16000000.00
EXPN.L cash_flow (annual, 2022-03-31) — Common Stock Payments: -173000000.00
EXPN.L income_statement (annual, 2022-03-31) — Cost Of Revenue: 3313000000.00
EXPN.L balance_sheet (annual, 2022-03-31) — Current Assets: 1673000000.00
EXPN.L balance_sheet (annual, 2022-03-31) — Current Capital Lease Obligation: 53000000.00
EXPN.L balance_sheet (annual, 2022-03-31) — Current Debt: 4000000.00
EXPN.L balance_sheet (annual, 2022-03-31) — Current Debt And Capital Lease Obligation: 57000000.00
EXPN.L balance_sheet (annual, 2022-03-31) — Current Liabilities: 1965000000.00
EXPN.L balance_sheet (annual, 2022-03-31) — Current Provisions: 33000000.00
EXPN.L balance_sheet (annual, 2022-03-31) — Defined Pension Benefit: 216000000.00
EXPN.L cash_flow (annual, 2022-03-31) — Depreciation: 658000000.00
EXPN.L cash_flow (annual, 2022-03-31) — Depreciation And Amortization: 658000000.00
EXPN.L income_statement (annual, 2022-03-31) — Depreciation And Amortization In Income Statement: 658000000.00
EXPN.L income_statement (annual, 2022-03-31) — Depreciation Income Statement: 484000000.00
EXPN.L balance_sheet (annual, 2022-03-31) — Derivative Product Liabilities: 226000000.00
EXPN.L income_statement (annual, 2022-03-31) — Diluted Average Shares: 921000000.00
EXPN.L income_statement (annual, 2022-03-31) — Diluted EPS: 1.27
EXPN.L income_statement (annual, 2022-03-31) — Diluted NI Availto Com Stockholders: 1165000000.00
EXPN.L cash_flow (annual, 2022-03-31) — Dividend Received Cfo: 13000000.00
EXPN.L cash_flow (annual, 2022-03-31) — Dividends Received Cfi: 2000000.00
EXPN.L income_statement (annual, 2022-03-31) — EBIT: 1572000000.00
EXPN.L income_statement (annual, 2022-03-31) — EBITDA: 2230000000.00
EXPN.L cash_flow (annual, 2022-03-31) — Effect Of Exchange Rate Changes: 14000000.00
EXPN.L cash_flow (annual, 2022-03-31) — End Cash Position: 176000000.00
EXPN.L balance_sheet (annual, 2022-03-31) — Financial Assets: 62000000.00
EXPN.L balance_sheet (annual, 2022-03-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 18000000.00
EXPN.L cash_flow (annual, 2022-03-31) — Financing Cash Flow: -687000000.00
EXPN.L cash_flow (annual, 2022-03-31) — Free Cash Flow: 1289000000.00
EXPN.L cash_flow (annual, 2022-03-31) — Gain Loss On Sale Of Business: -47000000.00
EXPN.L cash_flow (annual, 2022-03-31) — Gain Loss On Sale Of PPE: -4000000.00
EXPN.L balance_sheet (annual, 2022-03-31) — Goodwill: 5737000000.00
EXPN.L balance_sheet (annual, 2022-03-31) — Goodwill And Other Intangible Assets: 7951000000.00
EXPN.L balance_sheet (annual, 2022-03-31) — Gross PPE: 1155000000.00
EXPN.L income_statement (annual, 2022-03-31) — Gross Profit: 2975000000.00
EXPN.L balance_sheet (annual, 2022-03-31) — Hedging Assets Current: 7000000.00
EXPN.L income_statement (annual, 2022-03-31) — Interest Expense: 125000000.00
EXPN.L income_statement (annual, 2022-03-31) — Interest Expense Non Operating: 125000000.00
EXPN.L income_statement (annual, 2022-03-31) — Interest Income: 15000000.00
EXPN.L income_statement (annual, 2022-03-31) — Interest Income Non Operating: 15000000.00
EXPN.L cash_flow (annual, 2022-03-31) — Interest Paid Cfo: -127000000.00
EXPN.L cash_flow (annual, 2022-03-31) — Interest Received Cfo: 6000000.00
EXPN.L balance_sheet (annual, 2022-03-31) — Invested Capital: 3969000000.00
EXPN.L cash_flow (annual, 2022-03-31) — Investing Cash Flow: -1118000000.00
EXPN.L balance_sheet (annual, 2022-03-31) — Investmentin Financial Assets: 456000000.00
EXPN.L balance_sheet (annual, 2022-03-31) — Investmentsin Associatesat Cost: 4000000.00
EXPN.L cash_flow (annual, 2022-03-31) — Issuance Of Capital Stock: 16000000.00
EXPN.L cash_flow (annual, 2022-03-31) — Issuance Of Debt: 571000000.00
EXPN.L balance_sheet (annual, 2022-03-31) — Long Term Capital Lease Obligation: 126000000.00
EXPN.L balance_sheet (annual, 2022-03-31) — Long Term Debt: 3913000000.00
EXPN.L balance_sheet (annual, 2022-03-31) — Long Term Debt And Capital Lease Obligation: 4039000000.00
EXPN.L cash_flow (annual, 2022-03-31) — Long Term Debt Issuance: 571000000.00
EXPN.L cash_flow (annual, 2022-03-31) — Long Term Debt Payments: -583000000.00
EXPN.L balance_sheet (annual, 2022-03-31) — Long Term Equity Investment: 4000000.00
EXPN.L balance_sheet (annual, 2022-03-31) — Long Term Provisions: 4000000.00
EXPN.L balance_sheet (annual, 2022-03-31) — Machinery Furniture Equipment: 716000000.00
EXPN.L balance_sheet (annual, 2022-03-31) — Minority Interest: 38000000.00
EXPN.L income_statement (annual, 2022-03-31) — Minority Interests: -2000000.00
EXPN.L cash_flow (annual, 2022-03-31) — Net Business Purchase And Sale: -725000000.00
EXPN.L cash_flow (annual, 2022-03-31) — Net Common Stock Issuance: -157000000.00
EXPN.L balance_sheet (annual, 2022-03-31) — Net Debt: 3738000000.00
EXPN.L income_statement (annual, 2022-03-31) — Net Income: 1165000000.00
EXPN.L income_statement (annual, 2022-03-31) — Net Income Common Stockholders: 1165000000.00
EXPN.L income_statement (annual, 2022-03-31) — Net Income Continuous Operations: 1151000000.00
EXPN.L income_statement (annual, 2022-03-31) — Net Income Discontinuous Operations: 16000000.00
EXPN.L income_statement (annual, 2022-03-31) — Net Income From Continuing And Discontinued Operation: 1165000000.00
EXPN.L income_statement (annual, 2022-03-31) — Net Income From Continuing Operation Net Minority Interest: 1149000000.00
EXPN.L cash_flow (annual, 2022-03-31) — Net Income From Continuing Operations: 1447000000.00
EXPN.L income_statement (annual, 2022-03-31) — Net Income Including Noncontrolling Interests: 1167000000.00
EXPN.L cash_flow (annual, 2022-03-31) — Net Intangibles Purchase And Sale: -445000000.00
EXPN.L income_statement (annual, 2022-03-31) — Net Interest Income: -110000000.00
EXPN.L cash_flow (annual, 2022-03-31) — Net Investment Purchase And Sale: -20000000.00
EXPN.L cash_flow (annual, 2022-03-31) — Net Issuance Payments Of Debt: -12000000.00
EXPN.L cash_flow (annual, 2022-03-31) — Net Long Term Debt Issuance: -12000000.00
EXPN.L income_statement (annual, 2022-03-31) — Net Non Operating Interest Income Expense: -110000000.00
EXPN.L cash_flow (annual, 2022-03-31) — Net Other Financing Charges: -15000000.00
EXPN.L balance_sheet (annual, 2022-03-31) — Net PPE: 415000000.00
EXPN.L cash_flow (annual, 2022-03-31) — Net PPE Purchase And Sale: -40000000.00
EXPN.L balance_sheet (annual, 2022-03-31) — Net Tangible Assets: -3982000000.00
EXPN.L balance_sheet (annual, 2022-03-31) — Non Current Accrued Expenses: 10000000.00
EXPN.L balance_sheet (annual, 2022-03-31) — Non Current Deferred Revenue: 158000000.00
EXPN.L balance_sheet (annual, 2022-03-31) — Non Current Deferred Taxes Assets: 46000000.00
EXPN.L balance_sheet (annual, 2022-03-31) — Non Current Deferred Taxes Liabilities: 353000000.00
EXPN.L balance_sheet (annual, 2022-03-31) — Non Current Pension And Other Postretirement Benefit Plans: 52000000.00
EXPN.L income_statement (annual, 2022-03-31) — Normalized EBITDA: 2014000000.00
EXPN.L income_statement (annual, 2022-03-31) — Normalized Income: 977280000.00
EXPN.L cash_flow (annual, 2022-03-31) — Operating Cash Flow: 1797000000.00
EXPN.L income_statement (annual, 2022-03-31) — Operating Income: 1369000000.00
EXPN.L income_statement (annual, 2022-03-31) — Operating Revenue: 6288000000.00
EXPN.L balance_sheet (annual, 2022-03-31) — Ordinary Shares Number: 921600000.00
EXPN.L balance_sheet (annual, 2022-03-31) — Other Intangible Assets: 2214000000.00
EXPN.L cash_flow (annual, 2022-03-31) — Other Non Cash Items: -19000000.00
EXPN.L income_statement (annual, 2022-03-31) — Other Operating Expenses: 445000000.00
EXPN.L balance_sheet (annual, 2022-03-31) — Other Payable: 433000000.00
EXPN.L balance_sheet (annual, 2022-03-31) — Other Properties: 78000000.00
EXPN.L balance_sheet (annual, 2022-03-31) — Other Short Term Investments: 7000000.00
EXPN.L income_statement (annual, 2022-03-31) — Other Special Charges: -47000000.00
EXPN.L income_statement (annual, 2022-03-31) — Otherunder Preferred Stock Dividend: 0.00
EXPN.L balance_sheet (annual, 2022-03-31) — Payables: 1853000000.00
EXPN.L income_statement (annual, 2022-03-31) — Pretax Income: 1447000000.00
EXPN.L balance_sheet (annual, 2022-03-31) — Properties: 0.00
EXPN.L cash_flow (annual, 2022-03-31) — Purchase Of Business: -737000000.00
EXPN.L cash_flow (annual, 2022-03-31) — Purchase Of Intangibles: -445000000.00
EXPN.L cash_flow (annual, 2022-03-31) — Purchase Of Investment: -32000000.00
EXPN.L cash_flow (annual, 2022-03-31) — Purchase Of PPE: -63000000.00
EXPN.L income_statement (annual, 2022-03-31) — Reconciled Cost Of Revenue: 3313000000.00
EXPN.L income_statement (annual, 2022-03-31) — Reconciled Depreciation: 658000000.00
EXPN.L cash_flow (annual, 2022-03-31) — Repayment Of Debt: -583000000.00
EXPN.L cash_flow (annual, 2022-03-31) — Repurchase Of Capital Stock: -173000000.00
EXPN.L balance_sheet (annual, 2022-03-31) — Retained Earnings: 20157000000.00
EXPN.L cash_flow (annual, 2022-03-31) — Sale Of Business: 12000000.00
EXPN.L cash_flow (annual, 2022-03-31) — Sale Of Investment: 12000000.00
EXPN.L cash_flow (annual, 2022-03-31) — Sale Of PPE: 23000000.00
EXPN.L income_statement (annual, 2022-03-31) — Selling And Marketing Expense: 503000000.00
EXPN.L income_statement (annual, 2022-03-31) — Selling General And Administration: 503000000.00
EXPN.L balance_sheet (annual, 2022-03-31) — Share Issued: 970600000.00
EXPN.L income_statement (annual, 2022-03-31) — Special Income Charges: 47000000.00
EXPN.L cash_flow (annual, 2022-03-31) — Stock Based Compensation: 149000000.00
EXPN.L balance_sheet (annual, 2022-03-31) — Stockholders Equity: 3969000000.00
EXPN.L balance_sheet (annual, 2022-03-31) — Tangible Book Value: -3982000000.00
EXPN.L income_statement (annual, 2022-03-31) — Tax Effect Of Unusual Items: 44280000.00
EXPN.L income_statement (annual, 2022-03-31) — Tax Provision: 296000000.00
EXPN.L income_statement (annual, 2022-03-31) — Tax Rate For Calcs: 0.21
EXPN.L balance_sheet (annual, 2022-03-31) — Taxes Receivable: 37000000.00
EXPN.L cash_flow (annual, 2022-03-31) — Taxes Refund Paid: -366000000.00
EXPN.L balance_sheet (annual, 2022-03-31) — Total Assets: 10894000000.00
EXPN.L balance_sheet (annual, 2022-03-31) — Total Capitalization: 3969000000.00
EXPN.L balance_sheet (annual, 2022-03-31) — Total Debt: 4096000000.00
EXPN.L balance_sheet (annual, 2022-03-31) — Total Equity Gross Minority Interest: 4007000000.00
EXPN.L income_statement (annual, 2022-03-31) — Total Expenses: 4919000000.00
EXPN.L balance_sheet (annual, 2022-03-31) — Total Liabilities Net Minority Interest: 6887000000.00
EXPN.L balance_sheet (annual, 2022-03-31) — Total Non Current Assets: 9221000000.00
EXPN.L balance_sheet (annual, 2022-03-31) — Total Non Current Liabilities Net Minority Interest: 4922000000.00
EXPN.L income_statement (annual, 2022-03-31) — Total Operating Income As Reported: 1416000000.00
EXPN.L balance_sheet (annual, 2022-03-31) — Total Tax Payable: 109000000.00
EXPN.L income_statement (annual, 2022-03-31) — Total Unusual Items: 216000000.00
EXPN.L income_statement (annual, 2022-03-31) — Total Unusual Items Excluding Goodwill: 216000000.00
EXPN.L balance_sheet (annual, 2022-03-31) — Tradeand Other Payables Non Current: 248000000.00
EXPN.L balance_sheet (annual, 2022-03-31) — Treasury Shares Number: 49000000.00
EXPN.L balance_sheet (annual, 2022-03-31) — Treasury Stock: 1129000000.00
EXPN.L balance_sheet (annual, 2022-03-31) — Working Capital: -292000000.00
EXPN.L income_statement (annual, 2023-03-31) — +Operating Expense: 1903000000.00
EXPN.L income_statement (annual, 2023-03-31) — +Total Revenue: 6619000000.00
EXPN.L balance_sheet (annual, 2023-03-31) — Accounts Payable: 263000000.00
EXPN.L balance_sheet (annual, 2023-03-31) — Accounts Receivable: 1519000000.00
EXPN.L balance_sheet (annual, 2023-03-31) — Accumulated Depreciation: -748000000.00
EXPN.L balance_sheet (annual, 2023-03-31) — Additional Paid In Capital: 1799000000.00
EXPN.L income_statement (annual, 2023-03-31) — Amortization: 192000000.00
EXPN.L cash_flow (annual, 2023-03-31) — Amortization Cash Flow: 560000000.00
EXPN.L balance_sheet (annual, 2023-03-31) — Assets Held For Sale Current: 16000000.00
EXPN.L balance_sheet (annual, 2023-03-31) — Available For Sale Securities: 313000000.00
EXPN.L income_statement (annual, 2023-03-31) — Basic Average Shares: 914000000.00
EXPN.L income_statement (annual, 2023-03-31) — Basic EPS: 0.84
EXPN.L cash_flow (annual, 2023-03-31) — Beginning Cash Position: 176000000.00
EXPN.L balance_sheet (annual, 2023-03-31) — Buildings And Improvements: 351000000.00
EXPN.L cash_flow (annual, 2023-03-31) — Capital Expenditure: -627000000.00
EXPN.L balance_sheet (annual, 2023-03-31) — Capital Lease Obligations: 148000000.00
EXPN.L balance_sheet (annual, 2023-03-31) — Capital Stock: 96000000.00
EXPN.L balance_sheet (annual, 2023-03-31) — Cash And Cash Equivalents: 202000000.00
EXPN.L balance_sheet (annual, 2023-03-31) — Cash Cash Equivalents And Short Term Investments: 202000000.00
EXPN.L cash_flow (annual, 2023-03-31) — Cash Dividends Paid: -483000000.00
EXPN.L balance_sheet (annual, 2023-03-31) — Cash Equivalents: 100000000.00
EXPN.L balance_sheet (annual, 2023-03-31) — Cash Financial: 102000000.00
EXPN.L cash_flow (annual, 2023-03-31) — Change In Payable: 201000000.00
EXPN.L cash_flow (annual, 2023-03-31) — Change In Receivables: -171000000.00
EXPN.L cash_flow (annual, 2023-03-31) — Change In Working Capital: 30000000.00
EXPN.L cash_flow (annual, 2023-03-31) — Changes In Cash: 47000000.00
EXPN.L balance_sheet (annual, 2023-03-31) — Common Stock: 96000000.00
EXPN.L cash_flow (annual, 2023-03-31) — Common Stock Dividend Paid: -483000000.00
EXPN.L balance_sheet (annual, 2023-03-31) — Common Stock Equity: 3929000000.00
EXPN.L cash_flow (annual, 2023-03-31) — Common Stock Issuance: -119000000.00
EXPN.L cash_flow (annual, 2023-03-31) — Common Stock Payments: -194000000.00
EXPN.L income_statement (annual, 2023-03-31) — Cost Of Revenue: 3451000000.00
EXPN.L balance_sheet (annual, 2023-03-31) — Current Assets: 1794000000.00
EXPN.L balance_sheet (annual, 2023-03-31) — Current Capital Lease Obligation: 43000000.00
EXPN.L balance_sheet (annual, 2023-03-31) — Current Debt: 113000000.00
EXPN.L balance_sheet (annual, 2023-03-31) — Current Debt And Capital Lease Obligation: 156000000.00
EXPN.L balance_sheet (annual, 2023-03-31) — Current Liabilities: 2311000000.00
EXPN.L balance_sheet (annual, 2023-03-31) — Current Provisions: 56000000.00
EXPN.L balance_sheet (annual, 2023-03-31) — Defined Pension Benefit: 174000000.00
EXPN.L cash_flow (annual, 2023-03-31) — Depreciation: 114000000.00
EXPN.L cash_flow (annual, 2023-03-31) — Depreciation And Amortization: 674000000.00
EXPN.L income_statement (annual, 2023-03-31) — Depreciation And Amortization In Income Statement: 674000000.00
EXPN.L income_statement (annual, 2023-03-31) — Depreciation Income Statement: 482000000.00
EXPN.L balance_sheet (annual, 2023-03-31) — Derivative Product Liabilities: 195000000.00
EXPN.L income_statement (annual, 2023-03-31) — Diluted Average Shares: 921000000.00
EXPN.L income_statement (annual, 2023-03-31) — Diluted EPS: 0.84
EXPN.L income_statement (annual, 2023-03-31) — Diluted NI Availto Com Stockholders: 770000000.00
EXPN.L cash_flow (annual, 2023-03-31) — Dividend Received Cfo: 2000000.00
EXPN.L cash_flow (annual, 2023-03-31) — Dividends Received Cfi: 0.00
EXPN.L income_statement (annual, 2023-03-31) — EBIT: 1311000000.00
EXPN.L income_statement (annual, 2023-03-31) — EBITDA: 1985000000.00
EXPN.L cash_flow (annual, 2023-03-31) — Effect Of Exchange Rate Changes: -25000000.00
EXPN.L cash_flow (annual, 2023-03-31) — End Cash Position: 198000000.00
EXPN.L balance_sheet (annual, 2023-03-31) — Financial Assets: 132000000.00
EXPN.L balance_sheet (annual, 2023-03-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 16000000.00
EXPN.L cash_flow (annual, 2023-03-31) — Financing Cash Flow: -722000000.00
EXPN.L cash_flow (annual, 2023-03-31) — Free Cash Flow: 1090000000.00
EXPN.L cash_flow (annual, 2023-03-31) — Gain Loss On Sale Of Business: 0.00
EXPN.L cash_flow (annual, 2023-03-31) — Gain Loss On Sale Of PPE: 0.00
EXPN.L balance_sheet (annual, 2023-03-31) — Goodwill: 5575000000.00
EXPN.L balance_sheet (annual, 2023-03-31) — Goodwill And Other Intangible Assets: 7864000000.00
EXPN.L balance_sheet (annual, 2023-03-31) — Gross PPE: 1130000000.00
EXPN.L income_statement (annual, 2023-03-31) — Gross Profit: 3168000000.00
EXPN.L balance_sheet (annual, 2023-03-31) — Hedging Assets Current: 7000000.00
EXPN.L income_statement (annual, 2023-03-31) — Interest Expense: 137000000.00
EXPN.L income_statement (annual, 2023-03-31) — Interest Expense Non Operating: 137000000.00
EXPN.L income_statement (annual, 2023-03-31) — Interest Income: 13000000.00
EXPN.L income_statement (annual, 2023-03-31) — Interest Income Non Operating: 13000000.00
EXPN.L cash_flow (annual, 2023-03-31) — Interest Paid Cfo: -126000000.00
EXPN.L cash_flow (annual, 2023-03-31) — Interest Received Cfo: 8000000.00
EXPN.L balance_sheet (annual, 2023-03-31) — Invested Capital: 7880000000.00
EXPN.L cash_flow (annual, 2023-03-31) — Investing Cash Flow: -948000000.00
EXPN.L balance_sheet (annual, 2023-03-31) — Investmentin Financial Assets: 329000000.00
EXPN.L balance_sheet (annual, 2023-03-31) — Investmentsin Associatesat Cost: 12000000.00
EXPN.L cash_flow (annual, 2023-03-31) — Issuance Of Capital Stock: -119000000.00
EXPN.L cash_flow (annual, 2023-03-31) — Issuance Of Debt: 84000000.00
EXPN.L balance_sheet (annual, 2023-03-31) — Long Term Capital Lease Obligation: 105000000.00
EXPN.L balance_sheet (annual, 2023-03-31) — Long Term Debt: 3838000000.00
EXPN.L balance_sheet (annual, 2023-03-31) — Long Term Debt And Capital Lease Obligation: 3943000000.00
EXPN.L cash_flow (annual, 2023-03-31) — Long Term Debt Issuance: 84000000.00
EXPN.L cash_flow (annual, 2023-03-31) — Long Term Debt Payments: -1000000.00
EXPN.L balance_sheet (annual, 2023-03-31) — Long Term Equity Investment: 12000000.00
EXPN.L balance_sheet (annual, 2023-03-31) — Long Term Provisions: 3000000.00
EXPN.L balance_sheet (annual, 2023-03-31) — Machinery Furniture Equipment: 670000000.00
EXPN.L balance_sheet (annual, 2023-03-31) — Minority Interest: 35000000.00
EXPN.L income_statement (annual, 2023-03-31) — Minority Interests: -3000000.00
EXPN.L cash_flow (annual, 2023-03-31) — Net Business Purchase And Sale: -309000000.00
EXPN.L cash_flow (annual, 2023-03-31) — Net Common Stock Issuance: -313000000.00
EXPN.L balance_sheet (annual, 2023-03-31) — Net Debt: 3749000000.00
EXPN.L income_statement (annual, 2023-03-31) — Net Income: 770000000.00
EXPN.L income_statement (annual, 2023-03-31) — Net Income Common Stockholders: 770000000.00
EXPN.L income_statement (annual, 2023-03-31) — Net Income Continuous Operations: 773000000.00
EXPN.L income_statement (annual, 2023-03-31) — Net Income Discontinuous Operations: 0.00
EXPN.L income_statement (annual, 2023-03-31) — Net Income From Continuing And Discontinued Operation: 770000000.00
EXPN.L income_statement (annual, 2023-03-31) — Net Income From Continuing Operation Net Minority Interest: 770000000.00
EXPN.L cash_flow (annual, 2023-03-31) — Net Income From Continuing Operations: 1174000000.00
EXPN.L income_statement (annual, 2023-03-31) — Net Income Including Noncontrolling Interests: 773000000.00
EXPN.L cash_flow (annual, 2023-03-31) — Net Intangibles Purchase And Sale: -563000000.00
EXPN.L income_statement (annual, 2023-03-31) — Net Interest Income: -124000000.00
EXPN.L cash_flow (annual, 2023-03-31) — Net Investment Purchase And Sale: -12000000.00
EXPN.L cash_flow (annual, 2023-03-31) — Net Issuance Payments Of Debt: 192000000.00
EXPN.L cash_flow (annual, 2023-03-31) — Net Long Term Debt Issuance: 83000000.00
EXPN.L income_statement (annual, 2023-03-31) — Net Non Operating Interest Income Expense: -124000000.00
EXPN.L cash_flow (annual, 2023-03-31) — Net Other Financing Charges: -61000000.00
EXPN.L balance_sheet (annual, 2023-03-31) — Net PPE: 382000000.00
EXPN.L cash_flow (annual, 2023-03-31) — Net PPE Purchase And Sale: -64000000.00
EXPN.L cash_flow (annual, 2023-03-31) — Net Short Term Debt Issuance: 109000000.00
EXPN.L balance_sheet (annual, 2023-03-31) — Net Tangible Assets: -3935000000.00
EXPN.L balance_sheet (annual, 2023-03-31) — Non Current Accrued Expenses: 7000000.00
EXPN.L balance_sheet (annual, 2023-03-31) — Non Current Deferred Revenue: 132000000.00
EXPN.L balance_sheet (annual, 2023-03-31) — Non Current Deferred Taxes Assets: 37000000.00
EXPN.L balance_sheet (annual, 2023-03-31) — Non Current Deferred Taxes Liabilities: 223000000.00
EXPN.L balance_sheet (annual, 2023-03-31) — Non Current Pension And Other Postretirement Benefit Plans: 39000000.00
EXPN.L income_statement (annual, 2023-03-31) — Normalized EBITDA: 1935000000.00
EXPN.L income_statement (annual, 2023-03-31) — Normalized Income: 737100000.00
EXPN.L cash_flow (annual, 2023-03-31) — Operating Cash Flow: 1717000000.00
EXPN.L income_statement (annual, 2023-03-31) — Operating Income: 1265000000.00
EXPN.L income_statement (annual, 2023-03-31) — Operating Revenue: 6619000000.00
EXPN.L balance_sheet (annual, 2023-03-31) — Ordinary Shares Number: 919100000.00
EXPN.L balance_sheet (annual, 2023-03-31) — Other Intangible Assets: 2289000000.00
EXPN.L cash_flow (annual, 2023-03-31) — Other Non Cash Items: 154000000.00
EXPN.L balance_sheet (annual, 2023-03-31) — Other Non Current Liabilities: 1000000.00
EXPN.L income_statement (annual, 2023-03-31) — Other Operating Expenses: 659000000.00
EXPN.L balance_sheet (annual, 2023-03-31) — Other Payable: 480000000.00
EXPN.L balance_sheet (annual, 2023-03-31) — Other Properties: 109000000.00
EXPN.L balance_sheet (annual, 2023-03-31) — Other Short Term Investments: 7000000.00
EXPN.L income_statement (annual, 2023-03-31) — Otherunder Preferred Stock Dividend: 0.00
EXPN.L balance_sheet (annual, 2023-03-31) — Payables: 906000000.00
EXPN.L income_statement (annual, 2023-03-31) — Pretax Income: 1174000000.00
EXPN.L balance_sheet (annual, 2023-03-31) — Properties: 0.00
EXPN.L cash_flow (annual, 2023-03-31) — Purchase Of Business: -310000000.00
EXPN.L cash_flow (annual, 2023-03-31) — Purchase Of Intangibles: -563000000.00
EXPN.L cash_flow (annual, 2023-03-31) — Purchase Of Investment: -15000000.00
EXPN.L cash_flow (annual, 2023-03-31) — Purchase Of PPE: -64000000.00
EXPN.L income_statement (annual, 2023-03-31) — Reconciled Cost Of Revenue: 3451000000.00
EXPN.L income_statement (annual, 2023-03-31) — Reconciled Depreciation: 674000000.00
EXPN.L cash_flow (annual, 2023-03-31) — Repayment Of Debt: -1000000.00
EXPN.L cash_flow (annual, 2023-03-31) — Repurchase Of Capital Stock: -194000000.00
EXPN.L balance_sheet (annual, 2023-03-31) — Retained Earnings: 20447000000.00
EXPN.L cash_flow (annual, 2023-03-31) — Sale Of Business: 1000000.00
EXPN.L cash_flow (annual, 2023-03-31) — Sale Of Investment: 3000000.00
EXPN.L cash_flow (annual, 2023-03-31) — Sale Of PPE: 0.00
EXPN.L income_statement (annual, 2023-03-31) — Selling And Marketing Expense: 570000000.00
EXPN.L income_statement (annual, 2023-03-31) — Selling General And Administration: 570000000.00
EXPN.L balance_sheet (annual, 2023-03-31) — Share Issued: 971400000.00
EXPN.L income_statement (annual, 2023-03-31) — Special Income Charges: 0.00
EXPN.L cash_flow (annual, 2023-03-31) — Stock Based Compensation: 129000000.00
EXPN.L balance_sheet (annual, 2023-03-31) — Stockholders Equity: 3929000000.00
EXPN.L balance_sheet (annual, 2023-03-31) — Tangible Book Value: -3935000000.00
EXPN.L income_statement (annual, 2023-03-31) — Tax Effect Of Unusual Items: 17100000.00
EXPN.L income_statement (annual, 2023-03-31) — Tax Provision: 401000000.00
EXPN.L income_statement (annual, 2023-03-31) — Tax Rate For Calcs: 0.34
EXPN.L balance_sheet (annual, 2023-03-31) — Taxes Receivable: 50000000.00
EXPN.L cash_flow (annual, 2023-03-31) — Taxes Refund Paid: -525000000.00
EXPN.L balance_sheet (annual, 2023-03-31) — Total Assets: 10864000000.00
EXPN.L balance_sheet (annual, 2023-03-31) — Total Capitalization: 7767000000.00
EXPN.L balance_sheet (annual, 2023-03-31) — Total Debt: 4099000000.00
EXPN.L balance_sheet (annual, 2023-03-31) — Total Equity Gross Minority Interest: 3964000000.00
EXPN.L income_statement (annual, 2023-03-31) — Total Expenses: 5354000000.00
EXPN.L balance_sheet (annual, 2023-03-31) — Total Liabilities Net Minority Interest: 6900000000.00
EXPN.L balance_sheet (annual, 2023-03-31) — Total Non Current Assets: 9070000000.00
EXPN.L balance_sheet (annual, 2023-03-31) — Total Non Current Liabilities Net Minority Interest: 4589000000.00
EXPN.L income_statement (annual, 2023-03-31) — Total Operating Income As Reported: 1265000000.00
EXPN.L balance_sheet (annual, 2023-03-31) — Total Tax Payable: 163000000.00
EXPN.L income_statement (annual, 2023-03-31) — Total Unusual Items: 50000000.00
EXPN.L income_statement (annual, 2023-03-31) — Total Unusual Items Excluding Goodwill: 50000000.00
EXPN.L balance_sheet (annual, 2023-03-31) — Tradeand Other Payables Non Current: 46000000.00
EXPN.L balance_sheet (annual, 2023-03-31) — Treasury Shares Number: 52300000.00
EXPN.L balance_sheet (annual, 2023-03-31) — Treasury Stock: 1273000000.00
EXPN.L balance_sheet (annual, 2023-03-31) — Working Capital: -517000000.00
EXPN.L income_statement (annual, 2024-03-31) — +Operating Expense: 2254000000.00
EXPN.L income_statement (annual, 2024-03-31) — +Total Revenue: 7097000000.00
EXPN.L balance_sheet (annual, 2024-03-31) — Accounts Payable: 341000000.00
EXPN.L balance_sheet (annual, 2024-03-31) — Accounts Receivable: 1660000000.00
EXPN.L balance_sheet (annual, 2024-03-31) — Accumulated Depreciation: -785000000.00
EXPN.L balance_sheet (annual, 2024-03-31) — Additional Paid In Capital: 1819000000.00
EXPN.L income_statement (annual, 2024-03-31) — Amortization: 608000000.00
EXPN.L cash_flow (annual, 2024-03-31) — Amortization Cash Flow: 608000000.00
EXPN.L balance_sheet (annual, 2024-03-31) — Assets Held For Sale Current: 0.00
EXPN.L balance_sheet (annual, 2024-03-31) — Available For Sale Securities: 234000000.00
EXPN.L income_statement (annual, 2024-03-31) — Basic Average Shares: 913000000.00
EXPN.L income_statement (annual, 2024-03-31) — Basic EPS: 1.31
EXPN.L cash_flow (annual, 2024-03-31) — Beginning Cash Position: 198000000.00
EXPN.L balance_sheet (annual, 2024-03-31) — Buildings And Improvements: 364000000.00
EXPN.L cash_flow (annual, 2024-03-31) — Capital Expenditure: -640000000.00
EXPN.L balance_sheet (annual, 2024-03-31) — Capital Lease Obligations: 151000000.00
EXPN.L balance_sheet (annual, 2024-03-31) — Capital Stock: 97000000.00
EXPN.L balance_sheet (annual, 2024-03-31) — Cash And Cash Equivalents: 312000000.00
EXPN.L balance_sheet (annual, 2024-03-31) — Cash Cash Equivalents And Short Term Investments: 312000000.00
EXPN.L cash_flow (annual, 2024-03-31) — Cash Dividends Paid: -510000000.00
EXPN.L balance_sheet (annual, 2024-03-31) — Cash Equivalents: 141000000.00
EXPN.L balance_sheet (annual, 2024-03-31) — Cash Financial: 171000000.00
EXPN.L cash_flow (annual, 2024-03-31) — Change In Payable: 123000000.00
EXPN.L cash_flow (annual, 2024-03-31) — Change In Receivables: -155000000.00
EXPN.L cash_flow (annual, 2024-03-31) — Change In Working Capital: -32000000.00
EXPN.L cash_flow (annual, 2024-03-31) — Changes In Cash: 97000000.00
EXPN.L balance_sheet (annual, 2024-03-31) — Common Stock: 97000000.00
EXPN.L cash_flow (annual, 2024-03-31) — Common Stock Dividend Paid: -510000000.00
EXPN.L balance_sheet (annual, 2024-03-31) — Common Stock Equity: 4634000000.00
EXPN.L cash_flow (annual, 2024-03-31) — Common Stock Issuance: 16000000.00
EXPN.L cash_flow (annual, 2024-03-31) — Common Stock Payments: -120000000.00
EXPN.L income_statement (annual, 2024-03-31) — Cost Of Revenue: 3149000000.00
EXPN.L balance_sheet (annual, 2024-03-31) — Current Assets: 2078000000.00
EXPN.L balance_sheet (annual, 2024-03-31) — Current Capital Lease Obligation: 37000000.00
EXPN.L balance_sheet (annual, 2024-03-31) — Current Debt: 735000000.00
EXPN.L balance_sheet (annual, 2024-03-31) — Current Debt And Capital Lease Obligation: 772000000.00
EXPN.L balance_sheet (annual, 2024-03-31) — Current Liabilities: 2963000000.00
EXPN.L balance_sheet (annual, 2024-03-31) — Current Provisions: 28000000.00
EXPN.L balance_sheet (annual, 2024-03-31) — Defined Pension Benefit: 186000000.00
EXPN.L cash_flow (annual, 2024-03-31) — Depreciation: 106000000.00
EXPN.L cash_flow (annual, 2024-03-31) — Depreciation And Amortization: 714000000.00
EXPN.L income_statement (annual, 2024-03-31) — Depreciation And Amortization In Income Statement: 714000000.00
EXPN.L income_statement (annual, 2024-03-31) — Depreciation Income Statement: 106000000.00
EXPN.L balance_sheet (annual, 2024-03-31) — Derivative Product Liabilities: 225000000.00
EXPN.L income_statement (annual, 2024-03-31) — Diluted Average Shares: 921000000.00
EXPN.L income_statement (annual, 2024-03-31) — Diluted EPS: 1.30
EXPN.L income_statement (annual, 2024-03-31) — Diluted NI Availto Com Stockholders: 1199000000.00
EXPN.L cash_flow (annual, 2024-03-31) — Dividend Received Cfo: 0.00
EXPN.L income_statement (annual, 2024-03-31) — EBIT: 1703000000.00
EXPN.L income_statement (annual, 2024-03-31) — EBITDA: 2417000000.00
EXPN.L cash_flow (annual, 2024-03-31) — Effect Of Exchange Rate Changes: 5000000.00
EXPN.L cash_flow (annual, 2024-03-31) — End Cash Position: 300000000.00
EXPN.L balance_sheet (annual, 2024-03-31) — Financial Assets: 160000000.00
EXPN.L balance_sheet (annual, 2024-03-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 14000000.00
EXPN.L cash_flow (annual, 2024-03-31) — Financing Cash Flow: -551000000.00
EXPN.L cash_flow (annual, 2024-03-31) — Free Cash Flow: 1107000000.00
EXPN.L cash_flow (annual, 2024-03-31) — Gain Loss On Sale Of Business: -5000000.00
EXPN.L cash_flow (annual, 2024-03-31) — Gain Loss On Sale Of PPE: -1000000.00
EXPN.L balance_sheet (annual, 2024-03-31) — Goodwill: 5962000000.00
EXPN.L balance_sheet (annual, 2024-03-31) — Goodwill And Other Intangible Assets: 8399000000.00
EXPN.L balance_sheet (annual, 2024-03-31) — Gross PPE: 1164000000.00
EXPN.L income_statement (annual, 2024-03-31) — Gross Profit: 3948000000.00
EXPN.L balance_sheet (annual, 2024-03-31) — Hedging Assets Current: 9000000.00
EXPN.L income_statement (annual, 2024-03-31) — Interest Expense: 152000000.00
EXPN.L income_statement (annual, 2024-03-31) — Interest Expense Non Operating: 152000000.00
EXPN.L income_statement (annual, 2024-03-31) — Interest Income: 38000000.00
EXPN.L income_statement (annual, 2024-03-31) — Interest Income Non Operating: 38000000.00
EXPN.L cash_flow (annual, 2024-03-31) — Interest Paid Cfo: -160000000.00
EXPN.L cash_flow (annual, 2024-03-31) — Interest Received Cfo: 11000000.00
EXPN.L balance_sheet (annual, 2024-03-31) — Invested Capital: 8749000000.00
EXPN.L cash_flow (annual, 2024-03-31) — Investing Cash Flow: -1099000000.00
EXPN.L balance_sheet (annual, 2024-03-31) — Investmentin Financial Assets: 248000000.00
EXPN.L balance_sheet (annual, 2024-03-31) — Investmentsin Associatesat Cost: 11000000.00
EXPN.L cash_flow (annual, 2024-03-31) — Issuance Of Capital Stock: 16000000.00
EXPN.L cash_flow (annual, 2024-03-31) — Issuance Of Debt: 0.00
EXPN.L balance_sheet (annual, 2024-03-31) — Long Term Capital Lease Obligation: 114000000.00
EXPN.L balance_sheet (annual, 2024-03-31) — Long Term Debt: 3380000000.00
EXPN.L balance_sheet (annual, 2024-03-31) — Long Term Debt And Capital Lease Obligation: 3494000000.00
EXPN.L cash_flow (annual, 2024-03-31) — Long Term Debt Issuance: 0.00
EXPN.L cash_flow (annual, 2024-03-31) — Long Term Debt Payments: -7000000.00
EXPN.L balance_sheet (annual, 2024-03-31) — Long Term Equity Investment: 11000000.00
EXPN.L balance_sheet (annual, 2024-03-31) — Long Term Provisions: 3000000.00
EXPN.L balance_sheet (annual, 2024-03-31) — Machinery Furniture Equipment: 683000000.00
EXPN.L balance_sheet (annual, 2024-03-31) — Minority Interest: 35000000.00
EXPN.L income_statement (annual, 2024-03-31) — Minority Interests: -4000000.00
EXPN.L cash_flow (annual, 2024-03-31) — Net Business Purchase And Sale: -456000000.00
EXPN.L cash_flow (annual, 2024-03-31) — Net Common Stock Issuance: -104000000.00
EXPN.L balance_sheet (annual, 2024-03-31) — Net Debt: 3803000000.00
EXPN.L income_statement (annual, 2024-03-31) — Net Income: 1199000000.00
EXPN.L income_statement (annual, 2024-03-31) — Net Income Common Stockholders: 1199000000.00
EXPN.L income_statement (annual, 2024-03-31) — Net Income Continuous Operations: 1203000000.00
EXPN.L income_statement (annual, 2024-03-31) — Net Income From Continuing And Discontinued Operation: 1199000000.00
EXPN.L income_statement (annual, 2024-03-31) — Net Income From Continuing Operation Net Minority Interest: 1199000000.00
EXPN.L cash_flow (annual, 2024-03-31) — Net Income From Continuing Operations: 1551000000.00
EXPN.L income_statement (annual, 2024-03-31) — Net Income Including Noncontrolling Interests: 1203000000.00
EXPN.L cash_flow (annual, 2024-03-31) — Net Intangibles Purchase And Sale: -600000000.00
EXPN.L income_statement (annual, 2024-03-31) — Net Interest Income: -114000000.00
EXPN.L cash_flow (annual, 2024-03-31) — Net Investment Purchase And Sale: -6000000.00
EXPN.L cash_flow (annual, 2024-03-31) — Net Issuance Payments Of Debt: 102000000.00
EXPN.L cash_flow (annual, 2024-03-31) — Net Long Term Debt Issuance: -7000000.00
EXPN.L income_statement (annual, 2024-03-31) — Net Non Operating Interest Income Expense: -114000000.00
EXPN.L cash_flow (annual, 2024-03-31) — Net Other Financing Charges: 9000000.00
EXPN.L cash_flow (annual, 2024-03-31) — Net Other Investing Changes: 2000000.00
EXPN.L balance_sheet (annual, 2024-03-31) — Net PPE: 379000000.00
EXPN.L cash_flow (annual, 2024-03-31) — Net PPE Purchase And Sale: -39000000.00
EXPN.L cash_flow (annual, 2024-03-31) — Net Short Term Debt Issuance: 109000000.00
EXPN.L balance_sheet (annual, 2024-03-31) — Net Tangible Assets: -3765000000.00
EXPN.L balance_sheet (annual, 2024-03-31) — Non Current Accrued Expenses: 7000000.00
EXPN.L balance_sheet (annual, 2024-03-31) — Non Current Deferred Revenue: 83000000.00
EXPN.L balance_sheet (annual, 2024-03-31) — Non Current Deferred Taxes Assets: 55000000.00
EXPN.L balance_sheet (annual, 2024-03-31) — Non Current Deferred Taxes Liabilities: 129000000.00
EXPN.L balance_sheet (annual, 2024-03-31) — Non Current Pension And Other Postretirement Benefit Plans: 39000000.00
EXPN.L income_statement (annual, 2024-03-31) — Normalized EBITDA: 2449000000.00
EXPN.L income_statement (annual, 2024-03-31) — Normalized Income: 1223820116.05
EXPN.L cash_flow (annual, 2024-03-31) — Operating Cash Flow: 1747000000.00
EXPN.L income_statement (annual, 2024-03-31) — Operating Income: 1694000000.00
EXPN.L income_statement (annual, 2024-03-31) — Operating Revenue: 7097000000.00
EXPN.L balance_sheet (annual, 2024-03-31) — Ordinary Shares Number: 913089047.00
EXPN.L balance_sheet (annual, 2024-03-31) — Other Intangible Assets: 2437000000.00